MBX Biosciences, Inc.

Biotechnology • Healthcare • Carmel, IN, United States • MBX (NMS)

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

MBX Biosciences (MBX) Faces Platform Validation Challenge as Near-Term Hypoglycemia Data Catalyst in Q2 2026 May Lack Differentiation - Yahoo Finance

Yahoo Finance • Dec 15

MBX Biosciences (NASDAQ:MBX) Trading Down 8.4% - Here's Why - MarketBeat

MarketBeat • Jan 5

Mbx Biosciences stock hits all-time high of 34.85 USD - Investing.com

Investing.com • Dec 22

MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains - Seeking Alpha

Seeking Alpha • Dec 10

MBX Biosciences Announces Proposed Public Offering - GlobeNewswire

GlobeNewswire • Sep 22

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has MBX Biosciences, Inc. had layoffs?

No layoff events have been recorded for MBX Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does MBX Biosciences, Inc. have?

MBX Biosciences, Inc. has approximately 43 employees.

What industry is MBX Biosciences, Inc. in?

MBX Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is MBX Biosciences, Inc. a publicly traded company?

Yes, MBX Biosciences, Inc. is publicly traded under the ticker symbol MBX on the NMS. The company has a market capitalization of approximately $1.44 billion.

Where is MBX Biosciences, Inc. headquartered?

MBX Biosciences, Inc. is headquartered in Carmel, IN, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.